Age-related inflammation: The contribution of different organs, tissues and systems. How to face it for therapeutic approaches

E. Cevenini, C. Caruso, G. Candore, M. Capri, D. Nuzzo, G. Duro, C. Rizzo, G. Colonna-Romano, D. Lio, D. Di Carlo, M. G. Palmas, M. Scurti, E. Pini, C. Franceschi, S. Vasto

Research output: Contribution to journalArticle

Abstract

A typical feature of ageing is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers ("inflamm-ageing"). This status may slowly damage one or several organs, especially when unfavorable genetic polymorphisms and epigenetic alterations are concomitant, leading to an increased risk of frailty together with the onset of age-related chronic diseases. The contribution of different tissues (adipose tissue, muscle), organs (brain, liver), immune system and ecosystems (gut microbiota) to age-related inflammation ("inflamm-ageing") will be discussed in this review in the context of its onset/progression leading to site-restricted and systemic effects. Moreover, some of the possible strategies and therapies to counteract the different sources of molecular mediators which lead to the age-related inflammatory phenotype will be presented.

Original languageEnglish
Pages (from-to)609-618
Number of pages10
JournalCurrent Pharmaceutical Design
Volume16
Issue number6
DOIs
Publication statusPublished - 2010

Fingerprint

Inflammation
Genetic Polymorphisms
Age of Onset
Epigenomics
Ecosystem
Adipose Tissue
Immune System
Chronic Disease
Cytokines
Phenotype
Muscles
Liver
Brain
Therapeutics
Gastrointestinal Microbiome

Keywords

  • Age-related diseases
  • Ageing
  • Immunosenescence
  • Inflammation

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Medicine(all)

Cite this

Age-related inflammation : The contribution of different organs, tissues and systems. How to face it for therapeutic approaches. / Cevenini, E.; Caruso, C.; Candore, G.; Capri, M.; Nuzzo, D.; Duro, G.; Rizzo, C.; Colonna-Romano, G.; Lio, D.; Di Carlo, D.; Palmas, M. G.; Scurti, M.; Pini, E.; Franceschi, C.; Vasto, S.

In: Current Pharmaceutical Design, Vol. 16, No. 6, 2010, p. 609-618.

Research output: Contribution to journalArticle

Cevenini, E, Caruso, C, Candore, G, Capri, M, Nuzzo, D, Duro, G, Rizzo, C, Colonna-Romano, G, Lio, D, Di Carlo, D, Palmas, MG, Scurti, M, Pini, E, Franceschi, C & Vasto, S 2010, 'Age-related inflammation: The contribution of different organs, tissues and systems. How to face it for therapeutic approaches', Current Pharmaceutical Design, vol. 16, no. 6, pp. 609-618. https://doi.org/10.2174/138161210790883840
Cevenini, E. ; Caruso, C. ; Candore, G. ; Capri, M. ; Nuzzo, D. ; Duro, G. ; Rizzo, C. ; Colonna-Romano, G. ; Lio, D. ; Di Carlo, D. ; Palmas, M. G. ; Scurti, M. ; Pini, E. ; Franceschi, C. ; Vasto, S. / Age-related inflammation : The contribution of different organs, tissues and systems. How to face it for therapeutic approaches. In: Current Pharmaceutical Design. 2010 ; Vol. 16, No. 6. pp. 609-618.
@article{c9667d3cd01d49cfafee0814c0760dee,
title = "Age-related inflammation: The contribution of different organs, tissues and systems. How to face it for therapeutic approaches",
abstract = "A typical feature of ageing is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers ({"}inflamm-ageing{"}). This status may slowly damage one or several organs, especially when unfavorable genetic polymorphisms and epigenetic alterations are concomitant, leading to an increased risk of frailty together with the onset of age-related chronic diseases. The contribution of different tissues (adipose tissue, muscle), organs (brain, liver), immune system and ecosystems (gut microbiota) to age-related inflammation ({"}inflamm-ageing{"}) will be discussed in this review in the context of its onset/progression leading to site-restricted and systemic effects. Moreover, some of the possible strategies and therapies to counteract the different sources of molecular mediators which lead to the age-related inflammatory phenotype will be presented.",
keywords = "Age-related diseases, Ageing, Immunosenescence, Inflammation",
author = "E. Cevenini and C. Caruso and G. Candore and M. Capri and D. Nuzzo and G. Duro and C. Rizzo and G. Colonna-Romano and D. Lio and {Di Carlo}, D. and Palmas, {M. G.} and M. Scurti and E. Pini and C. Franceschi and S. Vasto",
year = "2010",
doi = "10.2174/138161210790883840",
language = "English",
volume = "16",
pages = "609--618",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Age-related inflammation

T2 - The contribution of different organs, tissues and systems. How to face it for therapeutic approaches

AU - Cevenini, E.

AU - Caruso, C.

AU - Candore, G.

AU - Capri, M.

AU - Nuzzo, D.

AU - Duro, G.

AU - Rizzo, C.

AU - Colonna-Romano, G.

AU - Lio, D.

AU - Di Carlo, D.

AU - Palmas, M. G.

AU - Scurti, M.

AU - Pini, E.

AU - Franceschi, C.

AU - Vasto, S.

PY - 2010

Y1 - 2010

N2 - A typical feature of ageing is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers ("inflamm-ageing"). This status may slowly damage one or several organs, especially when unfavorable genetic polymorphisms and epigenetic alterations are concomitant, leading to an increased risk of frailty together with the onset of age-related chronic diseases. The contribution of different tissues (adipose tissue, muscle), organs (brain, liver), immune system and ecosystems (gut microbiota) to age-related inflammation ("inflamm-ageing") will be discussed in this review in the context of its onset/progression leading to site-restricted and systemic effects. Moreover, some of the possible strategies and therapies to counteract the different sources of molecular mediators which lead to the age-related inflammatory phenotype will be presented.

AB - A typical feature of ageing is a chronic, low-grade inflammation characterized by a general increase in the production of pro-inflammatory cytokines and inflammatory markers ("inflamm-ageing"). This status may slowly damage one or several organs, especially when unfavorable genetic polymorphisms and epigenetic alterations are concomitant, leading to an increased risk of frailty together with the onset of age-related chronic diseases. The contribution of different tissues (adipose tissue, muscle), organs (brain, liver), immune system and ecosystems (gut microbiota) to age-related inflammation ("inflamm-ageing") will be discussed in this review in the context of its onset/progression leading to site-restricted and systemic effects. Moreover, some of the possible strategies and therapies to counteract the different sources of molecular mediators which lead to the age-related inflammatory phenotype will be presented.

KW - Age-related diseases

KW - Ageing

KW - Immunosenescence

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=77950199929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950199929&partnerID=8YFLogxK

U2 - 10.2174/138161210790883840

DO - 10.2174/138161210790883840

M3 - Article

C2 - 20388071

AN - SCOPUS:77950199929

VL - 16

SP - 609

EP - 618

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 6

ER -